Current Role(s): Chief Executive Officer, Sanofi; Chairman, Genzyme
Joined Genzyme: 2011
Christopher Viehbacher, born March 26, 1960, holds German and Canadian nationalities. He is a graduate of the Queens University (Ontario - Canada) and a certified public accountant.
After beginning his career at PriceWaterhouseCoopers, between 1988-2008 he acquired broad international experience in Europe, in the United States and in Canada with the GlaxoSmithKline (GSK) company. In his last position, Christopher Viehbacher was President, Pharmaceutical Operations North America, a member of the board and Co-Chairman of the Portfolio Management Board.
As from December 1, 2008, Christopher Viehbacher is a Sanofi board member, CEO and a member of the Strategy Committee. He is also Chairman of Genzyme since April 2011.
Christopher Viehbacher was Chairman of PhRMA in the United States (December 2010 – April 2012) and since February 2011, he was appointed Chair of the CEO Roundtable on Cancer. This association brings together employers across the United States to develop and implement workplace initiatives that reduce the risk of cancer, enable early diagnosis, facilitate better access to best-available treatments and hasten the discovery of novel and more effective diagnostic tools and anti-cancer therapies. Over 120 organizations are now members, covering nearly 3 million employees.
Christopher Viehbacher is married with three children. He speaks French, English and German: he lived in France for nine years when he was General Manager of GSK France. He was made a knight of the French Legion of Honor in 2003.